The Discovery of Novel Selective D1 Dopaminergic Agonists : A-68930, A-77636, A-86929, and ABT-413

Author

Martin, Yvonne Connolly

Source

International Journal of Medicinal Chemistry

Issue

Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2011-05-03

Country of Publication

Egypt

No. of Pages

8

Main Subjects

Chemistry
Pharmacology

Abstract EN

The novel selective D1 dopaminergic full agonists A-68930, A-77636 were discovered by the synthesis of molecules to probe the bioactive conformation of the partial agonist SKF-38393, by the use of this information to add D1 affinity and selectivity to a screening hit, and by traditional medicinal chemistry exploration of structure-activity relationships.

The subsequent design of A-86929 and ABT-413 capitalized on these results, recently disclosed agonists, and traditional medicinal chemistry.

American Psychological Association (APA)

Martin, Yvonne Connolly. 2011. The Discovery of Novel Selective D1 Dopaminergic Agonists : A-68930, A-77636, A-86929, and ABT-413. International Journal of Medicinal Chemistry،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-471099

Modern Language Association (MLA)

Martin, Yvonne Connolly. The Discovery of Novel Selective D1 Dopaminergic Agonists : A-68930, A-77636, A-86929, and ABT-413. International Journal of Medicinal Chemistry No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-471099

American Medical Association (AMA)

Martin, Yvonne Connolly. The Discovery of Novel Selective D1 Dopaminergic Agonists : A-68930, A-77636, A-86929, and ABT-413. International Journal of Medicinal Chemistry. 2011. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-471099

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-471099